Home / Stock ratings / Robotics and Automation Stocks / PATH

Stock rating · Services-Prepackaged Software

UiPath, Inc. (PATH) Stock Rating & Analysis

As of November 20, 2026, MELANY rates UiPath, Inc. 61 out of 100 (Hold). Its highest factor score is analyst sentiment at 78, and its lowest is earnings track record at 33.

MELANY ratingRated 2026-11-20

PATH · composite score

61/100
Hold
Nov 20
Rating date
Live price in the app →
Quality71
Momentum49
Risk-adjusted65
Source basis SEC filings and live market dataDated snapshot

About UiPath, Inc.

UiPath offers an end-to-end, cross-application enterprise automation platform built around computer vision technology and user interface automations from its original RPA offering, which remains the platform's foundation. The platform combines automation technologies including robotic process automation, application programming interfaces, and artificial intelligence. Its solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service.

Rating as of 2026-11-20 · this is a dated snapshot; the live rating and the live price are in the app (the rating is part of Pro, free for 30 days).

Why PATH scores 61/100

PATH's 8 factor scores run from 33 to 78, and 5 of them sit above its composite of 61. Here is how PATH breaks down.

Valuation72/100

Whether the price looks cheap or expensive against earnings, growth, and peers.

  • P/E 16.5x vs sector 28.0x median
  • PEG ratio 0.37 (< 1 = undervalued)
  • FCF yield 6.3%
Business quality71/100

Margins, returns on capital, and balance-sheet strength.

  • Gross margin 83%
  • ROE 20%
Price momentum49/100

Direction and relative strength of the recent share-price trend.

  • 50-day MA above 200-day (golden cross zone)
Earnings track record33/100

History of beating or missing estimates, and where estimates are heading.

Analyst sentiment78/100

What Wall Street price targets and revisions are signalling.

  • Analyst targets 39% upside
  • Institutional net buying +5.8%
Catalyst setup68/100

Near-term events that could move the stock.

Risk-adjusted profile65/100

Upside weighed against volatility and drawdown risk.

Macro fit50/100

How the current rate and market regime suits this kind of company.

How PATH compares

As of November 21, 2026, UiPath, Inc. ranks 5th of 14 in Robotics and Automation Stocks, where the average score is 58.

All stock rating pages.

Key risks for PATH

  • Short interest 24% of float, high volatility risk on news

Sector and theme context

UiPath, Inc. sits in the Technology sector theme, which MELANY currently rates 36/100 for strength. Theme strength feeds PATH's momentum and catalyst factors above.

Tracking PATH

UiPath, Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Add PATH to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.

How MELANY rates PATH

MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. UiPath, Inc.'s 61/100 reflects mature factor weighting for its profile.

Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.

Frequently asked questions about PATH

Is UiPath, Inc. (PATH) a buy?

As of 2026-11-20, MELANY rated UiPath, Inc. Hold with a composite score of 61/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.

How does PATH rank against similar companies?

As of November 21, 2026, UiPath, Inc. ranks 5th of 14 in MELANY's Robotics and Automation Stocks list, where the average score is 58. Among the other names in the list, the highest scores belong to ZBRA (66) and NVDA (65).

Should I buy UiPath, Inc. stock?

That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates UiPath, Inc. (PATH) Hold with a composite of 61/100 as of 2026-11-20. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.

What is the PATH stock price forecast?

MELANY does not publish price targets or forecasts for PATH. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 61/100 across eight factors for UiPath, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive. What it does read for PATH as of 2026-11-20: its analyst sentiment factor is 78/100 (Analyst targets 39% upside), and its price momentum factor is 49/100.

Is PATH stock overvalued or undervalued?

MELANY's valuation factor currently reads 72/100 for UiPath, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives PATH's read.

What price should I buy PATH at?

MELANY is not flagging a fresh entry for PATH at its current Hold rating, so there is no entry zone to publish right now. Add PATH to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.

What are the risks of buying PATH stock?

The top risks MELANY currently flags for UiPath, Inc.: Short interest 24% of float, high volatility risk on news. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.

Is UiPath, Inc. a good long-term investment?

For long-term durability the two factors that matter most are business quality, which MELANY scores 71/100 for UiPath, Inc., and earnings track record, at 33/100. The 61/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.

Will PATH stock go up?

Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 49/100 for PATH right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.

How current is this PATH rating?

The rating on this page is a snapshot of MELANY's read as of 2026-11-20, and the score is not recomputed on this page. MELANY re-scores PATH as new price, earnings, and fundamental data arrive; the current rating and the live price are in the app (the rating is part of Pro, free for 30 days).

How this rating works

Market Eyes Live

Every rating graded in public, PATH included

MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.

Get the free iOS app Create a free account on the web Free account, no card. Pro: 30 days free, then $9.99 a month.